Transmission of Infections during Cardiopulmonary Resuscitation.

COVID-19 SARS-CoV-2 airborne blood-borne cardiopulmonary infection resuscitation transmission

Journal

Clinical microbiology reviews
ISSN: 1098-6618
Titre abrégé: Clin Microbiol Rev
Pays: United States
ID NLM: 8807282

Informations de publication

Date de publication:
15 12 2021
Historique:
pubmed: 29 7 2021
medline: 21 12 2021
entrez: 28 7 2021
Statut: ppublish

Résumé

Cardiopulmonary resuscitation (CPR) is an emergency lifesaving endeavor, performed in either the hospital or outpatient settings, that significantly improves outcomes and survival rates when performed in a timely fashion. As with any other medical procedure, CPR can bear potential risks not only for the patient but also for the rescuer. Among those risks, transmission of an infectious agent has been one of the most compelling triggers of reluctance to perform CPR among providers. The concern for transmission of an infection from the resuscitated subject may impede prompt initiation and implementation of CPR, compromising survival rates and neurological outcomes of the patients. Infections during CPR can be potentially acquired through airborne, droplet, contact, or hematogenous transmission. However, only a few cases of infection transmission have been actually reported globally. In this review, we present the available epidemiological findings on transmission of different pathogens during CPR and data on reluctance of health care workers to perform CPR. We also outline the levels of personal protective equipment and other protective measures according to potential infectious hazards that providers are potentially exposed to during CPR and summarize current guidelines on protection of CPR providers from international societies and stakeholders.

Identifiants

pubmed: 34319149
doi: 10.1128/CMR.00018-21
pmc: PMC8404692
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0001821

Auteurs

Paraskevi C Fragkou (PC)

Fourth Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

Dimitra Dimopoulou (D)

Third Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

George Latsios (G)

First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

Panagiotis Koudounis (P)

First Department of Cardiology, Korgialenio-Benakio General Hospital, Athens, Greece.

Andreas Synetos (A)

First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

Anastasia Dimopoulou (A)

Department of Pediatric Surgery, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

Konstantinos Tsioufis (K)

First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.

Vassiliki Papaevangelou (V)

Third Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

Sotirios Tsiodras (S)

Fourth Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH